Celldex Therapeutics, Inc. Repayments of Secured Debt
Celldex Therapeutics, Inc. (CLDX) reported Repayments of Secured Debt of $11.03 million for the 12-month period ending 2013-12-31, per its 10-K/A filed 2016-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSecuredDebt · last filed 2016-02-25
- Celldex Therapeutics, Inc. repayments of secured debt for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- Celldex Therapeutics, Inc. repayments of secured debt for the quarter ending 2013-09-30 was $0.00.
- Celldex Therapeutics, Inc. repayments of secured debt for the quarter ending 2013-06-30 was $9.71M.
- Celldex Therapeutics, Inc. repayments of secured debt for the quarter ending 2013-03-31 was $1.32M.
- Celldex Therapeutics, Inc. repayments of secured debt for fiscal 2013 was $11.03M, a 177.74% increase from fiscal 2012.
- Celldex Therapeutics, Inc. repayments of secured debt for fiscal 2012 was $3.97M.
| Period end | Repayments of Secured Debt 3 month | Repayments of Secured Debt 6 month | Repayments of Secured Debt 9 month | Repayments of Secured Debt 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $9.71M derived: sum of 3 quarters · filed 2016-02-25 | $11.03M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $9.71M derived: sum of 2 quarters · filed 2014-11-05 | $11.03M 10-Q · filed 2014-11-05 | $12.35M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $9.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $11.03M 10-Q · filed 2014-08-07 | $12.35M derived: sum of 3 quarters · filed 2015-02-24 | |
| 2013-03-31 | $1.32M 10-Q · filed 2014-05-01 | $2.65M derived: sum of 2 quarters · filed 2015-02-24 | ||
| 2012-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $3.97M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $2.65M 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |